Patara Pharma Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 3

Patara Pharma General Information

Description

Developer of therapy for the treatment of allergic and inflammatory diseases. The company is engaged in developing a new therapy for the treatment of allergic and immunologic diseases and conditions that affect orphan patient populations, providing patients with the drug required for their treatment.

Contact Information

Website
www.patarapharma.com
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Corporate Office
  • 11455 El Camino Real
  • Suite 460
  • San Diego, CA 92130
  • United States
Primary Industry
Drug Discovery
Acquirer
Roivant Sciences
Vertical(s)
Life Sciences
Corporate Office
  • 11455 El Camino Real
  • Suite 460
  • San Diego, CA 92130
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Patara Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Patara Pharma‘s full profile, request access.

Request a free trial

Patara Pharma Patents

  • 32

    Total Documents Applications and Grants

  • Total Patents Families

  • 14

    Granted

  • 2

    Pending

  • Expiring in next 12 mo

Patara Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-10463613-B2 Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis Inactive 31-Aug-2016
US-20180193259-A1 Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis Active 31-Aug-2016
US-20200155452-A1 Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis Inactive 31-Aug-2016
US-20190175503-A1 Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis Active 31-Aug-2016
US-10265267-B2 Cromolyn compositions for treatment of chronic cough due to idiopathic pulmonary fibrosis Inactive 31-Aug-2016 A61K9/0078
To view Patara Pharma’s complete patent history, request access »

Patara Pharma Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Patara Pharma‘s full profile, request access.

Request a free trial

Patara Pharma FAQs

  • When was Patara Pharma founded?

    Patara Pharma was founded in 2013.

  • Where is Patara Pharma headquartered?

    Patara Pharma is headquartered in San Diego, CA.

  • What industry is Patara Pharma in?

    Patara Pharma’s primary industry is Drug Discovery.

  • Is Patara Pharma a private or public company?

    Patara Pharma is a Private company.

  • What is Patara Pharma’s current revenue?

    The current revenue for Patara Pharma is .

  • How much funding has Patara Pharma raised over time?

    Patara Pharma has raised $32M.

  • Who are Patara Pharma’s investors?

    Bridgewest Group, City Hill Ventures, and Hunt Companies have invested in Patara Pharma.

  • When was Patara Pharma acquired?

    Patara Pharma was acquired on 04-Sep-2018.

  • Who acquired Patara Pharma?

    Patara Pharma was acquired by Roivant Sciences.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »